NCT06879717
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06879717
Title A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients (PULMO-01)
Acronym PULMO-01
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors iOnctura
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | ESP | BEL


No variant requirements are available.